Ryan Zimmerman
Stock Analyst at BTIG
(4.12)
# 518
Out of 4,981 analysts
187
Total ratings
53.8%
Success rate
11.99%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Reiterates: Buy | $118 | $82.80 | +42.51% | 11 | Sep 10, 2025 | |
| SI Shoulder Innovations | Reiterates: Buy | $23 | $15.84 | +45.20% | 1 | Sep 9, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $39 | $19.75 | +97.47% | 8 | Aug 6, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $566 → $571 | $449.16 | +27.13% | 18 | Jul 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $145 → $148 | $134.22 | +10.27% | 7 | Jul 14, 2025 | |
| RXST RxSight | Downgrades: Neutral | n/a | $9.27 | - | 5 | Jul 9, 2025 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $58.72 | - | 15 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $32.05 | +105.93% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $272.66 | -0.98% | 19 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $383.24 | +2.81% | 15 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.47 | +580.27% | 4 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $106 | $78.34 | +35.31% | 11 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $15.04 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $126 | $102.92 | +22.43% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $76.45 | +30.80% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $73.45 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $27.86 | +90.24% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.63 | +376.19% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.28 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.52 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.95 | +105.13% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.97 | +20.85% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.80 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.09 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $13.49 | +107.56% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $147.00 | +36.05% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $340.66 | +2.74% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $36.99 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $94.28 | +35.77% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.56 | +19.47% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $64.41 | +41.28% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.87 | +135.10% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.75 | +1,005.26% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.55 | - | 3 | Apr 2, 2020 |
Glaukos
Sep 10, 2025
Reiterates: Buy
Price Target: $118
Current: $82.80
Upside: +42.51%
Shoulder Innovations
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $15.84
Upside: +45.20%
OrthoPediatrics
Aug 6, 2025
Maintains: Buy
Price Target: $40 → $39
Current: $19.75
Upside: +97.47%
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $566 → $571
Current: $449.16
Upside: +27.13%
Abbott Laboratories
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $134.22
Upside: +10.27%
RxSight
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $9.27
Upside: -
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $58.72
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $32.05
Upside: +105.93%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $272.66
Upside: -0.98%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $383.24
Upside: +2.81%
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $1.47
Upside: +580.27%
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $78.34
Upside: +35.31%
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $15.04
Upside: -
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $102.92
Upside: +22.43%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $76.45
Upside: +30.80%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $73.45
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $27.86
Upside: +90.24%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.63
Upside: +376.19%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.28
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.52
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.95
Upside: +105.13%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $4.97
Upside: +20.85%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.80
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.09
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $13.49
Upside: +107.56%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $147.00
Upside: +36.05%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $340.66
Upside: +2.74%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $36.99
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $94.28
Upside: +35.77%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.56
Upside: +19.47%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $64.41
Upside: +41.28%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.87
Upside: +135.10%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.75
Upside: +1,005.26%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $16.55
Upside: -